Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
54,300
+5,000 (10.14%)
Nov 20, 2025, 3:30 PM KST
10.14%
Market Cap1.89T
Revenue (ttm)23.23B
Net Income (ttm)-13.14B
Shares Out38.26M
EPS (ttm)-343.12
PE Ration/a
Forward PE221.08
Dividendn/a
Ex-Dividend Daten/a
Volume688,529
Average Volume432,640
Open50,400
Previous Close49,300
Day's Range48,200 - 55,500
52-Week Range21,600 - 55,900
Beta1.48
RSI65.32
Earnings DateNov 14, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.